Chlorhexidine

Its positive charge promotes attraction to negatively charged structures on microbial cell envelopes. After binding, chlorhexidine disrupts membrane integrity, increasing leakage of cellular contents and compromising cell survival. This charge-dependent interaction explains why the compound acts at the cell surface rather than relying only on penetration into the interior of the microorganism.

Chlorhexidine has an affinity for tissue surfaces, allowing some of the compound to remain associated with those surfaces after application. This persistence can extend antimicrobial activity beyond the immediate contact period. The effect is not fixed, however, because formulation, concentration, exposure time, and the organisms present all influence the resulting level of protection.

Effectiveness depends on the formulation used, its concentration, the length of microbial exposure, and the susceptibility of the organisms encountered. These variables mean that results can differ between clinical uses and microbial targets. A formulation that performs well in one setting should not automatically be assumed to provide the same degree of activity elsewhere.

Broad-spectrum activity does not mean activity against every microbial form. Chlorhexidine has limited effectiveness against some spores, so it should not be treated as universally reliable for all contamination risks. In addition, exposure may cause irritation or allergic reactions. These limitations make appropriate clinical selection and use important when planning antiseptic care.

Clinical applications include surgical skin preparations, hand antiseptics, oral rinses, and protocols intended to reduce infection associated with medical devices. The target may be skin, mucous membranes, or a clinical surface, depending on the formulation and setting. Its use therefore spans preparation, routine antisepsis, oral care, and device-related infection prevention.

Application decisions should consider the intended site, the formulation, concentration, exposure time, and organisms likely to be present. These conditions directly affect antimicrobial performance, while tissue tolerance remains relevant because irritation or allergy can occur. Matching the product and clinical protocol to the situation helps support contamination reduction without assuming identical results across settings.

In device-related protocols, chlorhexidine serves as one component of an approach to reducing microbial contamination around clinical devices. Its tissue-surface affinity may support continued antimicrobial activity after application, but performance still depends on formulation, concentration, exposure time, and the organisms involved. Limited activity against some spores and possible reactions also require appropriate use.